SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Recent filings
Filed 2024-03-27 17:12
Tx date 2024-03-25
$EPI
ESSA Pharma Inc.
Lauren, Merendino
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$225,999
+25,000 vol
$9.04 each
75,000
Filed 2024-03-27 17:06
Tx date 2024-03-25
$EPI
ESSA Pharma Inc.
Kantoff, Philip Wayne
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$451,999
+50,000 vol
$9.04 each
100,000
Filed 2024-03-27 17:05
Tx date 2024-03-25
$EPI
ESSA Pharma Inc.
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$451,999
+50,000 vol
$9.04 each
139,000
Filed 2024-03-27 17:03
Tx date 2024-03-25
$EPI
ESSA Pharma Inc.
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$451,999
+50,000 vol
$9.04 each
139,000
Filed 2024-03-27 17:02
Tx date 2024-03-25
$EPI
ESSA Pharma Inc.
Zweifach, Sanford
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$451,999
+50,000 vol
$9.04 each
139,000
Filed 2024-03-27 17:00
Tx date 2024-03-25
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$451,999
+50,000 vol
$9.04 each
156,000
Filed 2024-03-27 16:58
Tx date 2024-03-25
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$451,999
+50,000 vol
$9.04 each
113,793
Filed 2024-03-27 16:57
Tx date 2024-03-25
$EPI
ESSA Pharma Inc.
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$451,999
+50,000 vol
$9.04 each
156,000
Filed 2024-03-27 16:24
Tx date 2024-03-25
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$632,799
+70,000 vol
$9.04 each
207,000
Filed 2024-03-27 16:21
Tx date 2024-03-25
$EPI
ESSA Pharma Inc.
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,807,999
+200,000 vol
$9.04 each
830,000
Filed 2024-03-27 16:18
Tx date 2024-03-25
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$994,399
+110,000 vol
$9.04 each
835,000
Filed 2024-03-27 16:16
Tx date 2024-03-25
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$994,399
+110,000 vol
$9.04 each
1,722,500
Filed 2024-03-27 16:12
Tx date 2024-03-25
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$3,163,999
+350,000 vol
$9.04 each
2,618,896
Older filings
Filed 2024-03-05 13:34
Tx date 2024-03-05
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-6,232.12
-694 vol
$8.98 each
12,634
Filed 2024-02-06 19:10
Tx date 2024-01-16
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,549
+1,718 vol
$3.23 each
15,740
Filed 2024-02-06 19:09
Tx date 2024-01-16
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-5,549.14
-1,718 vol
$3.23 each
1,685,782
Filed 2024-02-06 19:04
Tx date 2024-01-16
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-17,180
-1,718 vol
$10.00 each
14,022
Filed 2024-02-06 19:04
Tx date 2024-01-16
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$5,549
+1,718 vol
$3.23 each
Filed 2024-02-06 18:59
Tx date 2024-02-05
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,615
+500 vol
$3.23 each
13,328
Filed 2024-02-06 18:56
Tx date 2024-02-05
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-1,615
-500 vol
$3.23 each
1,685,282
Filed 2024-02-06 18:53
Tx date 2024-02-05
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$1,615
+500 vol
$3.23 each
Filed 2024-02-06 18:50
Tx date 2024-02-06
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-748,926.78
-72,782 vol
$10.29 each
13,328
Filed 2024-02-06 18:49
Tx date 2024-02-06
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$235,085
+72,782 vol
$3.23 each
86,110
Filed 2024-02-06 18:46
Tx date 2024-02-06
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-235,085.86
-72,782 vol
$3.23 each
1,612,500
Filed 2024-02-06 13:19
Tx date 2024-02-05
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-5,020
-500 vol
$10.04 each
13,328
Filed 2024-02-06 13:15
Tx date 2024-02-05
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$1,615
+500 vol
$3.23 each
13,828
Filed 2024-02-06 13:15
Tx date 2024-02-05
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$1,615
+500 vol
$3.23 each
Filed 2024-02-06 13:01
Tx date 2024-02-05
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-6,419.50
-694 vol
$9.25 each
13,328
Filed 2024-01-17 19:38
Tx date 2024-01-16
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-5,549.14
-1,718 vol
$3.23 each
Filed 2024-01-17 19:38
Tx date 2024-01-16
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-5,549.14
-1,718 vol
$3.23 each
1,685,782
Filed 2024-01-12 14:29
Tx date 2023-11-06
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

-12,500 vol
30,002
Filed 2024-01-12 14:28
Tx date 2023-10-30
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

-17,502 vol
42,502
Filed 2024-01-11 16:35
Tx date 2024-01-05
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-4,270.89
-699 vol
$6.11 each
14,022
Filed 2023-12-18 19:54
Tx date 2023-12-14
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$21,249
+9,223 vol
$2.30 each
65,765
Filed 2023-11-23 19:33
Tx date 2023-10-24
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$14,662
+3,750 vol
$3.91 each
725,000
Filed 2023-11-23 19:31
Tx date 2023-10-01
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-3,750 vol
721,250
Filed 2023-11-22 16:51
Tx date 2023-11-21
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$134,821
+23,529 vol
$5.73 each
784,404
Filed 2023-11-09 16:02
Tx date 2023-11-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$98,661
+16,471 vol
$5.99 each
760,875
Filed 2023-11-09 16:01
Tx date 2023-11-02
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$321,240
+60,000 vol
$5.35 each
744,404
Filed 2023-07-07 18:37
Tx date 2023-06-06
$EPI
ESSA Pharma Inc.
Lauren, Merendino
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
50,000
Filed 2023-01-05 17:29
Tx date 2022-12-22
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$51,067
+21,367 vol
$2.39 each
53,475
Filed 2023-01-05 13:43
Tx date 2022-12-30
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,974
+3,067 vol
$2.60 each
35,175
Filed 2023-01-05 13:40
Tx date 2022-12-30
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$21,585
+8,302 vol
$2.60 each
33,343
Filed 2023-01-05 13:36
Tx date 2022-12-21
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-83,088.28
-34,334 vol
$2.42 each
684,404
Filed 2023-01-05 13:36
Tx date 2022-12-21
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-91,312.49
-37,889 vol
$2.41 each
718,738
Filed 2023-01-05 13:35
Tx date 2022-12-20
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-110,351.01
-43,617 vol
$2.53 each
756,627
Filed 2023-01-05 13:34
Tx date 2022-12-16
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-133,500
-50,000 vol
$2.67 each
800,244
Filed 2023-01-05 13:33
Tx date 2022-12-15
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-143,000
-50,000 vol
$2.86 each
850,244
Filed 2023-01-05 13:32
Tx date 2022-12-15
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-92,800
-32,000 vol
$2.90 each
900,244
Filed 2023-01-05 13:32
Tx date 2022-12-14
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-75,000
-25,000 vol
$3.00 each
932,244
Filed 2022-11-03 18:37
Tx date 2021-05-26
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Common Shares
72 - Other settlement of third party derivative

+3,622 vol
28,622
Filed 2022-10-27 14:44
Tx date 2022-06-29
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+90,000 vol
1,687,500
Filed 2022-10-27 13:42
Tx date 2022-06-29
$EPI
ESSA Pharma Inc.
Zweifach, Sanford
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+22,500 vol
89,000
Filed 2022-10-27 13:40
Tx date 2022-06-29
$EPI
ESSA Pharma Inc.
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+90,000 vol
630,000
Filed 2022-10-27 13:35
Tx date 2022-06-29
$EPI
ESSA Pharma Inc.
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+22,500 vol
89,000
Filed 2022-10-27 13:33
Tx date 2022-06-29
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+90,000 vol
725,000
Filed 2022-10-27 13:31
Tx date 2022-06-29
$EPI
ESSA Pharma Inc.
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+22,500 vol
89,000
Filed 2022-10-27 13:29
Tx date 2022-06-29
$EPI
ESSA Pharma Inc.
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+22,500 vol
106,000
Filed 2022-10-27 13:27
Tx date 2022-06-29
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+22,500 vol
63,793
Filed 2022-10-27 13:25
Tx date 2022-06-29
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+35,000 vol
137,000
Filed 2022-10-27 13:21
Tx date 2022-06-29
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+22,500 vol
106,000
Filed 2022-10-27 13:17
Tx date 2022-06-29
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+222,500 vol
2,268,896
Filed 2022-09-21 13:03
Tx date 2022-09-13
$EPI
ESSA Pharma Inc.
Kantoff, Philip Wayne
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
50,000
Filed 2022-09-21 12:58
Tx date 2022-09-13
$EPI
ESSA Pharma Inc.
Kantoff, Philip Wayne
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-07-15 15:56
Tx date 2022-07-11
$EPI
ESSA Pharma Inc.
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: MSI BVF SPV, L.L.C. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$191,722
+72,076 vol
$2.66 each
186,788
Filed 2022-07-15 15:55
Tx date 2022-07-08
$EPI
ESSA Pharma Inc.
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: MSI BVF SPV, L.L.C. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
114,712
Filed 2022-07-15 15:55
Tx date 2022-07-11
$EPI
ESSA Pharma Inc.
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: Biotechnology Value Trading Fund O.S., L.P. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$559,068
+210,176 vol
$2.66 each
357,472
Filed 2022-07-15 15:54
Tx date 2022-07-08
$EPI
ESSA Pharma Inc.
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: Biotechnology Value Trading Fund O.S., L.P. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
147,296
Filed 2022-07-15 15:54
Tx date 2022-07-11
$EPI
ESSA Pharma Inc.
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: Biotechnology Value Fund II, L.P. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$4,764,863
+1,791,302 vol
$2.66 each
3,491,779
Filed 2022-07-15 15:53
Tx date 2022-07-08
$EPI
ESSA Pharma Inc.
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: Biotechnology Value Fund II, L.P. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
1,700,477
Filed 2022-07-15 15:53
Tx date 2022-07-11
$EPI
ESSA Pharma Inc.
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: Biotechnology Value Fund, L.P. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$5,922,346
+2,226,446 vol
$2.66 each
4,712,590
Filed 2022-07-15 15:52
Tx date 2022-07-08
$EPI
ESSA Pharma Inc.
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: Biotechnology Value Fund, L.P. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
2,486,144
Filed 2022-07-05 11:41
Tx date 2022-06-30
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$14,455
+4,887 vol
$2.96 each
32,108
Filed 2022-01-28 13:13
Tx date 2022-01-10
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Common Shares
72 - Other settlement of third party derivative

+31,382 vol
56,382
Filed 2021-07-07 16:21
Tx date 2021-07-06
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$12,306
+1,246 vol
$9.88 each
25,041
Filed 2021-07-07 16:13
Tx date 2021-07-06
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$12,306
+1,246 vol
$9.88 each
14,721
Filed 2021-07-07 16:11
Tx date 2021-07-06
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$12,306
+1,246 vol
$9.88 each
27,221
Filed 2021-07-07 15:56
Tx date 2021-07-06
$EPI
ESSA Pharma Inc.
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,511
+153 vol
$9.88 each
5,124
Filed 2021-07-04 16:38
Tx date 2021-06-30
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,938
+905 vol
$9.88 each
13,475
Filed 2021-07-04 16:31
Tx date 2021-06-30
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,938
+905 vol
$9.88 each
23,795
Filed 2021-07-04 16:27
Tx date 2021-06-30
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,938
+905 vol
$9.88 each
25,975
Filed 2021-07-04 16:22
Tx date 2021-06-30
$EPI
ESSA Pharma Inc.
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,938
+905 vol
$9.88 each
4,971
Filed 2021-03-03 18:25
Tx date 2021-02-22
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$1,539,000
+57,000 vol
$27.00 each
957,244
Filed 2021-01-05 15:29
Tx date 2020-09-25
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$8,832
+1,380 vol
$6.40 each
8,460
Filed 2020-12-31 12:58
Tx date 2020-12-30
$EPI
ESSA Pharma Inc.
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,247
+1,970 vol
$5.20 each
4,066
Filed 2020-12-28 13:49
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$700,000
+100,000 vol
$7.00 each
535,000
Filed 2020-12-28 13:44
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$402,500
+57,500 vol
$7.00 each
482,500
Filed 2020-12-14 16:31
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$402,500
+57,500 vol
$7.00 each
Filed 2020-12-14 15:55
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$700,000
+100,000 vol
$7.00 each
Filed 2020-12-15 15:57
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$402,500
+57,500 vol
$7.00 each
540,000
Filed 2020-12-15 15:54
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$700,000
+100,000 vol
$7.00 each
635,000
Filed 2020-12-15 15:47
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$1,400,000
+200,000 vol
$7.00 each
1,597,500
Filed 2020-12-15 15:42
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$1,868,636
+266,948 vol
$7.00 each
2,046,396
Filed 2020-12-15 13:56
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Brettman, Ari
1 - Issuer
Direct Ownership
Options
50 - Grant of options
$115,500
+16,500 vol
$7.00 each
66,500
Filed 2020-12-15 13:51
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Zweifach, Sanford
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$115,500
+16,500 vol
$7.00 each
66,500
Filed 2020-12-15 13:45
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$115,500
+16,500 vol
$7.00 each
66,500
Filed 2020-12-15 13:40
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$115,500
+16,500 vol
$7.00 each
66,500
Filed 2020-12-15 12:50
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$115,500
+16,500 vol
$7.00 each
83,500
Filed 2020-12-14 18:49
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$115,500
+16,500 vol
$7.00 each
41,293
Filed 2020-12-14 18:45
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$115,500
+16,500 vol
$7.00 each
83,500
Filed 2020-12-14 16:39
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$175,000
+25,000 vol
$7.00 each
102,000
Filed 2020-12-14 16:31
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$402,500
+57,500 vol
$7.00 each
482,500
Filed 2020-12-14 15:55
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$700,000
+100,000 vol
$7.00 each
535,000
Filed 2020-12-14 15:49
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$1,400,000
+200,000 vol
$7.00 each
1,397,500
Filed 2020-12-14 15:44
Tx date 2020-12-11
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$1,868,636
+266,948 vol
$7.00 each
1,779,448
Filed 2020-12-14 14:48
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-8,321.04
-2,184 vol
$3.81 each
31,566
Filed 2020-12-14 14:48
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-26,136
-6,534 vol
$4.00 each
33,750
Filed 2020-12-14 14:48
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-80,750
-25,000 vol
$3.23 each
40,284
Filed 2020-12-14 14:47
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-6,864
-1,716 vol
$4.00 each
65,284
Filed 2020-12-14 14:47
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$31,629
+6,773 vol
$4.67 each
900,244
Filed 2020-12-14 14:46
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$8,321
+2,184 vol
$3.81 each
893,471
Filed 2020-12-14 14:46
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$8,321
+2,184 vol
$3.81 each
Filed 2020-12-14 14:45
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$80,750
+25,000 vol
$3.23 each
884,753
Filed 2020-12-14 14:45
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$6,864
+1,716 vol
$4.00 each
859,753
Filed 2020-12-14 14:44
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-31,629.91
-6,773 vol
$4.67 each
24,793
Filed 2020-12-14 14:42
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$31,629
+6,773 vol
$4.67 each
Filed 2020-12-14 14:41
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$8,321
+2,184 vol
$3.81 each
Filed 2020-12-14 14:40
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$26,136
+6,534 vol
$4.00 each
891,287
Filed 2020-12-14 14:39
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$80,750
+25,000 vol
$3.23 each
Filed 2020-12-14 14:38
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$6,864
+1,716 vol
$4.00 each
Filed 2020-12-14 14:37
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-31,629.91
-6,773 vol
$4.67 each
Filed 2020-12-14 14:36
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-8,321.04
-2,184 vol
$3.81 each
Filed 2020-12-14 14:36
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-26,136
-6,534 vol
$4.00 each
Filed 2020-12-14 14:35
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-80,750
-25,000 vol
$3.23 each
Filed 2020-12-14 14:34
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-6,864
-1,716 vol
$4.00 each
Filed 2020-12-14 14:33
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$80,750
+25,000 vol
$3.23 each
Filed 2020-12-14 14:33
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$6,864
+1,716 vol
$4.00 each
Filed 2020-12-14 14:33
Tx date 2020-12-02
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$26,136
+6,534 vol
$4.00 each
Filed 2020-12-14 14:33
Tx date 2020-12-02
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$80,750
+25,000 vol
$3.23 each
Filed 2020-12-14 14:28
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$80,750
+25,000 vol
$3.23 each
Filed 2020-12-14 14:25
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$8,321
+2,184 vol
$3.81 each
Filed 2020-12-14 14:24
Tx date 2020-12-02
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$26,136
+6,534 vol
$4.00 each
Filed 2020-12-14 14:23
Tx date 2020-12-02
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$80,750
+25,000 vol
$3.23 each
Filed 2020-12-14 14:22
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$6,864
+1,716 vol
$4.00 each
Filed 2020-12-14 14:21
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$27,456
+6,864 vol
$4.00 each
Filed 2020-12-14 14:18
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$27,456
+6,864 vol
$4.00 each
Filed 2020-12-14 14:07
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-31,629.91
-6,773 vol
$4.67 each
Filed 2020-12-14 14:04
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-8,321.04
-2,184 vol
$3.81 each
Filed 2020-12-14 14:01
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-26,136
-6,534 vol
$4.00 each
Filed 2020-12-14 14:00
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-80,750
-25,000 vol
$3.23 each
Filed 2020-12-14 13:57
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-6,864
-1,716 vol
$4.00 each
Filed 2020-12-14 13:57
Tx date 2020-12-03
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-6,864
-1,716 vol
$4.00 each
65,284
Filed 2020-09-24 15:55
Tx date 2020-09-24
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$9,585
+1,500 vol
$6.39 each
7,080
Filed 2020-09-24 15:53
Tx date 2020-09-23
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$3,712
+580 vol
$6.40 each
5,580
Filed 2020-09-24 15:41
Tx date 2020-09-23
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$36,736
+5,740 vol
$6.40 each
39,490
Filed 2020-08-25 13:59
Tx date 2020-08-21
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$171,024
+24,088 vol
$7.10 each
858,037
Filed 2020-08-25 13:58
Tx date 2020-08-20
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$138,370
+19,529 vol
$7.09 each
833,949
Filed 2020-08-25 13:57
Tx date 2020-08-19
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$349,280
+50,000 vol
$6.99 each
814,420
Filed 2020-08-21 14:13
Tx date 2020-08-17
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$680,000
+100,000 vol
$6.80 each
764,420
Filed 2020-08-21 14:12
Tx date 2020-08-17
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$47,600
+7,000 vol
$6.80 each
664,420
Filed 2020-08-04 14:25
Tx date 2020-07-31
$EPI
ESSA Pharma Inc.
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$1,200,000
+200,000 vol
$6.00 each
3,573,053
Filed 2020-08-04 14:23
Tx date 2019-08-27
$EPI
ESSA Pharma Inc.
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$3,408,986
+1,704,493 vol
$2.00 each
3,373,053
Filed 2020-08-04 13:57
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-31,702,652 vol
1,668,560
Filed 2020-08-04 13:09
Tx date 2020-07-31
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$600,000
+100,000 vol
$6.00 each
657,420
Filed 2020-08-04 13:03
Tx date 2020-07-31
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$150,000
+25,000 vol
$6.00 each
25,000
Filed 2020-08-04 13:02
Tx date 2016-01-14
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-04 12:51
Tx date 2020-07-31
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$49,998
+8,333 vol
$6.00 each
12,570
Filed 2020-08-04 12:45
Tx date 2020-07-31
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$49,998
+8,333 vol
$6.00 each
25,070
Filed 2018-04-25 17:24
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-31,702,651 vol
Filed 2020-07-02 14:21
Tx date 2020-06-29
$EPI
ESSA Pharma Inc.
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$10,249
+2,096 vol
$4.89 each
2,096
Filed 2020-07-02 14:21
Tx date 2018-07-15
$EPI
ESSA Pharma Inc.
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-02 14:19
Tx date 2020-06-29
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$20,718
+4,237 vol
$4.89 each
4,237
Filed 2020-07-02 14:17
Tx date 2016-08-01
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-02 14:14
Tx date 2020-06-30
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,098
+2,000 vol
$6.05 each
22,890
Filed 2020-07-02 14:13
Tx date 2020-06-29
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$20,410
+4,174 vol
$4.89 each
20,890
Filed 2020-07-02 14:09
Tx date 2020-06-29
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$20,718
+4,237 vol
$4.89 each
16,737
Filed 2020-06-18 14:36
Tx date 2020-06-15
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$150.35
+31 vol
$4.85 each
16,716
Filed 2020-03-02 18:34
Tx date 2020-03-02
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,584
+916 vol
$5.00 each
557,420
Filed 2020-03-02 18:33
Tx date 2020-03-02
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$67,685
+14,094 vol
$4.80 each
556,504
Filed 2020-02-24 13:39
Tx date 2020-02-21
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$540,000
+100,000 vol
$5.40 each
542,410
Filed 2020-02-20 16:20
Tx date 2020-02-20
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$270,000
+50,000 vol
$5.40 each
442,410
Filed 2020-02-20 16:19
Tx date 2020-02-19
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$805,860
+150,000 vol
$5.37 each
392,410
Filed 2020-02-20 16:17
Tx date 2020-02-19
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$158,764
+29,565 vol
$5.37 each
242,410
Filed 2020-01-17 17:10
Tx date 2020-01-17
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
99 - Correction of information

-273,843 vol
212,845
Filed 2020-01-17 17:07
Tx date 2020-01-17
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
99 - Correction of information

-273,843 vol
Filed 2019-11-05 12:06
Tx date 2019-11-04
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,200
+200 vol
$6.00 each
16,685
Filed 2019-11-01 15:50
Tx date 2019-10-30
$EPI
ESSA Pharma Inc.
Brettman, Ari
1 - Issuer
Direct Ownership
Options
50 - Grant of options
$116,750
+25,000 vol
$4.67 each
50,000
Filed 2019-11-01 15:46
Tx date 2019-10-30
$EPI
ESSA Pharma Inc.
Zweifach, Sanford
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$116,750
+25,000 vol
$4.67 each
50,000
Filed 2019-11-01 15:44
Tx date 2019-10-30
$EPI
ESSA Pharma Inc.
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$116,750
+25,000 vol
$4.67 each
50,000
Filed 2019-11-01 15:42
Tx date 2019-10-30
$EPI
ESSA Pharma Inc.
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$116,750
+25,000 vol
$4.67 each
50,000
Filed 2019-11-01 15:39
Tx date 2019-10-30
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$116,750
+25,000 vol
$4.67 each
67,000
Filed 2019-11-01 15:35
Tx date 2019-10-30
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$116,750
+25,000 vol
$4.67 each
67,000
Filed 2019-11-01 15:32
Tx date 2019-10-30
$EPI
ESSA Pharma Inc.
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$116,750
+25,000 vol
$4.67 each
67,000
Filed 2019-11-01 15:26
Tx date 2019-10-30
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$116,750
+25,000 vol
$4.67 each
77,000
Filed 2019-11-01 15:11
Tx date 2019-11-01
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,350
+2,300 vol
$4.50 each
16,485
Filed 2019-11-01 15:11
Tx date 2019-10-31
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$45,000
+100 vol
$450.00 each
14,185
Filed 2019-11-01 15:04
Tx date 2019-10-31
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$32,255
+7,000 vol
$4.61 each
486,688
Filed 2019-10-22 09:58
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
Brettman, Ari
1 - Issuer
Direct Ownership
Options
50 - Grant of options
$80,750
+25,000 vol
$3.23 each
25,000
Filed 2019-10-22 09:55
Tx date 2019-10-17
$EPI
ESSA Pharma Inc.
Brettman, Ari
1 - Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-10-21 15:57
Tx date 2019-10-17
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,154
+2,000 vol
$3.58 each
464,688
Filed 2019-10-18 17:16
Tx date 2019-10-18
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$55,140
+15,000 vol
$3.68 each
477,688
Filed 2019-10-16 14:13
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,292,000
+400,000 vol
$3.23 each
425,000
Filed 2019-10-16 14:10
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,065,900
+330,000 vol
$3.23 each
435,000
Filed 2019-10-16 14:07
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$3,133,100
+970,000 vol
$3.23 each
1,197,500
Filed 2019-10-16 14:04
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$553,848
+171,470 vol
$3.23 each
1,512,500
Filed 2019-10-16 14:02
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$3,322,151
+1,028,530 vol
$3.23 each
1,341,030
Filed 2019-10-16 13:58
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
Zweifach, Sanford
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,750
+25,000 vol
$3.23 each
25,000
Filed 2019-10-16 13:57
Tx date 2019-07-31
$EPI
ESSA Pharma Inc.
Zweifach, Sanford
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-10-16 13:55
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,750
+25,000 vol
$3.23 each
25,000
Filed 2019-10-16 13:53
Tx date 2019-07-31
$EPI
ESSA Pharma Inc.
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-10-16 13:49
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,750
+25,000 vol
$3.23 each
25,000
Filed 2019-10-16 13:48
Tx date 2019-07-31
$EPI
ESSA Pharma Inc.
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-10-16 13:42
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
Stampacchi, Otello
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,750
+25,000 vol
$3.23 each
42,000
Filed 2019-10-16 13:37
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,750
+25,000 vol
$3.23 each
42,000
Filed 2019-10-16 13:33
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,750
+25,000 vol
$3.23 each
42,000
Filed 2019-10-16 13:13
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,750
+25,000 vol
$3.23 each
42,000
Filed 2019-10-16 13:09
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$80,750
+25,000 vol
$3.23 each
Filed 2019-10-16 13:04
Tx date 2019-10-07
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$96,900
+30,000 vol
$3.23 each
52,000
Filed 2019-10-09 18:37
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-95 vol
2,505
Filed 2019-10-09 18:35
Tx date 2015-05-29
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$925.00
+100 vol
$9.25 each
100
Filed 2019-10-09 18:27
Tx date 2019-10-08
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$21,824
+6,400 vol
$3.41 each
14,085
Filed 2019-10-03 18:17
Tx date 2019-10-02
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,025
+250 vol
$4.10 each
7,680
Filed 2019-09-11 17:07
Tx date 2019-09-10
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$920.50
+350 vol
$2.63 each
7,430
Filed 2019-09-11 12:11
Tx date 2019-09-09
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,520
+900 vol
$2.80 each
7,080
Filed 2019-09-11 12:10
Tx date 2019-09-06
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,972
+680 vol
$2.90 each
6,180
Filed 2019-08-30 14:04
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-47,500 vol
2,500
Filed 2019-08-28 11:08
Tx date 2019-08-27
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,899
+3,000 vol
$2.30 each
53,000
Filed 2019-08-09 13:42
Tx date 2019-07-31
$EPI
ESSA Pharma Inc.
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,881
Filed 2019-08-09 13:31
Tx date 2019-07-31
$EPI
ESSA Pharma Inc.
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
14,299
Filed 2019-07-19 12:15
Tx date 2018-07-15
$EPI
ESSA Pharma Inc.
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
25,000
Filed 2019-02-12
Tx date 2019-02-08
$EPI
ESSA Pharma Inc.
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$25,299
+5,000 vol
$5.06 each
17,000
Filed 2019-02-12
Tx date 2019-02-08
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$50,599
+10,000 vol
$5.06 each
22,000
Filed 2019-02-12
Tx date 2019-02-08
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$19,050
+5,000 vol
$3.81 each
17,000
Filed 2019-02-12
Tx date 2019-02-08
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$152,400
+40,000 vol
$3.81 each
227,500
Filed 2019-02-12
Tx date 2019-02-08
$EPI
ESSA Pharma Inc.
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$63,249
+12,500 vol
$5.06 each
92,500
Filed 2019-02-12
Tx date 2019-02-08
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$19,050
+5,000 vol
$3.81 each
17,000
Filed 2019-02-12
Tx date 2019-02-08
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$95,250
+25,000 vol
$3.81 each
105,000
Filed 2019-02-12
Tx date 2019-02-08
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$171,450
+45,000 vol
$3.81 each
312,500
Filed 2019-02-12
Tx date 2019-02-08
$EPI
ESSA Pharma Inc.
Stampacchi, Otello
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$19,050
+5,000 vol
$3.81 each
17,000
Filed 2019-02-12
Tx date 2019-02-08
$EPI
ESSA Pharma Inc.
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$63,249
+12,500 vol
$5.06 each
92,500
Filed 2018-10-22
Tx date 2018-10-18
$EPI
ESSA Pharma Inc.
Stampacchi, Otello
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-10-22
Tx date 2018-10-18
$EPI
ESSA Pharma Inc.
Stampacchi, Otello
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$42,996
+12,000 vol
$3.58 each
12,000
Filed 2018-04-26
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-190,000 vol
80,000
Filed 2018-04-26
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-1,330,000 vol
270,000
Filed 2018-04-26
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-3,562,500 vol
187,500
Filed 2018-04-26
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-228,000 vol
12,000
Filed 2018-04-26
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-1,520,000 vol
80,000
Filed 2018-04-26
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-228,000 vol
12,000
Filed 2018-04-26
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-47,500 vol
267,500
Filed 2018-04-26
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-5,035,000 vol
315,000
Filed 2018-04-26
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-228,000 vol
12,000
Filed 2018-04-26
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-95,000 vol
5,000
Filed 2018-04-26
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-641,250 vol
33,750
Filed 2018-04-26
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Beekman, Hugo
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-228,000 vol
12,000
Filed 2018-04-26
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-1,520,000 vol
80,000
Filed 2018-04-26
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-228,000 vol
12,000
Filed 2018-04-25
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-2,744,831 vol
144,465
Filed 2018-04-25
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-237,500 vol
12,500
Filed 2018-04-25
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-31,702,651 vol
1,668,561
Filed 2018-04-25
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-3,314,204 vol
462,688
Filed 2018-04-25
Tx date 2018-04-25
$EPI
ESSA Pharma Inc.
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-2,744,831 vol
141,465
Filed 2018-03-06
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$29,400
+120,000 vol
$0.245 each
240,000
Filed 2018-03-06
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$29,400
+120,000 vol
$0.245 each
120,000
Filed 2018-03-06
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
$-96,000
-120,000 vol
$0.80 each
0
Filed 2018-03-06
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$40,425
+165,000 vol
$0.245 each
240,000
Filed 2018-03-06
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$18,375
+75,000 vol
$0.245 each
75,000
Filed 2018-03-06
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
$-60,000
-75,000 vol
$0.80 each
0
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$324,625
+1,325,000 vol
$0.245 each
1,600,000
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$49,000
+200,000 vol
$0.245 each
275,000
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$18,375
+75,000 vol
$0.245 each
75,000
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
$-400,000
-200,000 vol
$2.00 each
0
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
$-60,000
-75,000 vol
$0.80 each
200,000
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$692,000
+3,460,000 vol
$0.20 each
3,750,000
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$58,000
+290,000 vol
$0.20 each
290,000
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$750,000
+3,750,000 vol
$0.20 each
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
$-1,012,100
-290,000 vol
$3.49 each
0
Filed 2018-03-05
Tx date 2018-03-05
$EPI
ESSA Pharma Inc.
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-240,000
-300,000 vol
$0.80 each
1,600,000
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$392,000
+1,600,000 vol
$0.245 each
1,900,000
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$48,000
+240,000 vol
$0.20 each
240,000
Filed 2018-03-05
Tx date 2016-01-14
$EPI
ESSA Pharma Inc.
Requadt, Scott
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$120,000
+600,000 vol
$0.20 each
5,350,000
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$10,000
+50,000 vol
$0.20 each
4,750,000
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$10,000
+50,000 vol
$0.20 each
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$130,000
+650,000 vol
$0.20 each
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$940,000
+4,700,000 vol
$0.20 each
4,700,000
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$1,070,000
+5,350,000 vol
$0.20 each
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$940,000
+4,700,000 vol
$0.20 each
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$1,070,000
+5,350,000 vol
$0.20 each
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$1,070,000
+5,350,000 vol
$0.20 each
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-600,000 vol
0
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-50,000 vol
600,000
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$38,000
+190,000 vol
$0.20 each
240,000
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$10,000
+50,000 vol
$0.20 each
50,000
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
$-267,500
-50,000 vol
$5.35 each
0
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Beekman, Hugo
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$48,000
+240,000 vol
$0.20 each
240,000
Filed 2018-03-05
Tx date 2018-03-05
$EPI
ESSA Pharma Inc.
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-240,000
-300,000 vol
$0.80 each
Filed 2018-03-05
Tx date 2018-02-21
$EPI
ESSA Pharma Inc.
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$392,000
+1,600,000 vol
$0.245 each
1,600,000
Filed 2018-03-05
Tx date 2018-01-31
$EPI
ESSA Pharma Inc.
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-240,000
-300,000 vol
$0.80 each
0
Filed 2018-02-09
Tx date 2018-01-09
$EPI
ESSA Pharma Inc.
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$6,250,000
+31,250,000 vol
$0.20 each
33,371,212
Filed 2018-02-06
Tx date 2018-02-02
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$13,500
+50,000 vol
$0.27 each
50,000
Filed 2018-02-06
Tx date 2014-12-08
$EPI
ESSA Pharma Inc.
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-30
Tx date 2018-01-16
$EPI
ESSA Pharma Inc.
Beekman, Hugo
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-19
Tx date 2018-01-18
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,717
+29,856 vol
$0.225 each
Filed 2018-01-19
Tx date 2018-01-17
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,396
+40,000 vol
$0.2099 each
3,776,892
Filed 2018-01-19
Tx date 2018-01-17
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$31,500
+150,000 vol
$0.21 each
3,736,892
Filed 2018-01-19
Tx date 2018-01-17
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,848
+58,400 vol
$0.22 each
3,586,892
Filed 2018-01-19
Tx date 2018-01-17
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,848
+58,400 vol
$0.22 each
Filed 2018-01-19
Tx date 2018-01-17
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,717
+29,856 vol
$0.225 each
3,528,492
Filed 2018-01-19
Tx date 2018-01-16
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,100
+10,000 vol
$0.21 each
3,498,636
Filed 2018-01-19
Tx date 2018-01-16
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,100
+10,000 vol
$0.21 each
Filed 2018-01-16
Tx date 2018-01-09
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$50,000
+250,000 vol
$0.20 each
250,000
Filed 2018-01-16
Tx date 2015-06-24
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-16
Tx date 2018-01-09
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$625,000
+3,125,000 vol
$0.20 each
3,488,636
Filed 2016-08-12
Tx date 2016-08-09
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$1,012,100
+290,000 vol
$3.49 each
290,000
Filed 2016-08-09
Tx date 2016-08-01
$EPI
ESSA Pharma Inc.
Virsik, Peter
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-23
Tx date 2016-03-21
$EPI
ESSA Pharma Inc.
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$-1,111,698
-370,566 vol
$3.00 each
2,886,296
Filed 2016-03-22
Tx date 2016-03-21
$EPI
ESSA Pharma Inc.
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$-1,111,698
-370,566 vol
$3.00 each
2,889,296
Filed 2016-02-02
Tx date 2016-01-29
$EPI
ESSA Pharma Inc.
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-60,000
-120,000 vol
$0.50 each
300,000
Filed 2016-02-02
Tx date 2016-01-29
$EPI
ESSA Pharma Inc.
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$53,431
+106,862 vol
$0.50 each
3,259,862
Filed 2016-02-02
Tx date 2016-01-29
$EPI
ESSA Pharma Inc.
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-60,000
-120,000 vol
$0.50 each
300,000
Filed 2016-02-02
Tx date 2016-01-29
$EPI
ESSA Pharma Inc.
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$53,431
+106,862 vol
$0.50 each
3,256,862
Filed 2016-01-18
Tx date 2016-01-14
$EPI
ESSA Pharma Inc.
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
3,181,818
Filed 2016-01-18
Tx date 2016-01-14
$EPI
ESSA Pharma Inc.
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Special Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-01-18
Tx date 2016-01-14
$EPI
ESSA Pharma Inc.
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Special Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-01-18
Tx date 2016-01-14
$EPI
ESSA Pharma Inc.
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,121,212
Filed 2016-01-18
Tx date 2016-01-14
$EPI
ESSA Pharma Inc.
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-01-18
Tx date 2016-01-14
$EPI
ESSA Pharma Inc.
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-01-15
Tx date 2016-01-12
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
650,000
Filed 2016-01-15
Tx date 2016-01-12
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
150,000
Filed 2015-12-07
Tx date 2015-06-24
$EPI
ESSA Pharma Inc.
Parkinson, David
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
50,000
Filed 2015-10-16
Tx date 2015-10-09
$EPI
ESSA Pharma Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership

-70,000 vol
675,000
Filed 2015-10-12
Tx date 2015-10-09
$EPI
ESSA Pharma Inc.
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-840.00
-120 vol
$7.00 each
3,150,000
Filed 2015-10-12
Tx date 2015-10-07
$EPI
ESSA Pharma Inc.
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$807.84
+120 vol
$6.73 each
3,150,120
Filed 2015-09-25
Tx date 2015-09-24
$EPI
ESSA Pharma Inc.
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$32,389
+3,600 vol
$9.00 each
2,504,800
Filed 2015-09-01
Tx date 2015-08-31
$EPI
ESSA Pharma Inc.
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-167,200
-22,000 vol
$7.60 each
3,153,000
Filed 2015-09-01
Tx date 2015-08-31
$EPI
ESSA Pharma Inc.
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-190,000
-25,000 vol
$7.60 each
3,150,000
Filed 2015-07-14
Tx date 2015-01-27
$EPI
ESSA Pharma Inc.
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: SPOUSE (Indirect Ownership)
Special Warrants
54 - Exercise of warrants

-100 vol
0
Filed 2015-07-14
Tx date 2014-12-08
$EPI
ESSA Pharma Inc.
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: SPOUSE (Indirect Ownership)
Special Warrants
00 - Opening Balance-Initial SEDI Report
100
Filed 2015-07-14
Tx date 2015-01-27
$EPI
ESSA Pharma Inc.
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Special Warrants
54 - Exercise of warrants

-200 vol
0
Filed 2015-07-14
Tx date 2014-12-08
$EPI
ESSA Pharma Inc.
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Special Warrants
00 - Opening Balance-Initial SEDI Report
200
Filed 2015-07-14
Tx date 2015-01-27
$EPI
ESSA Pharma Inc.
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants

+200 vol
2,501,200
Filed 2015-07-14
Tx date 2014-12-08
$EPI
ESSA Pharma Inc.
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-07-14
Tx date 2014-12-08
$EPI
ESSA Pharma Inc.
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,500,000
Filed 2015-07-14
Tx date 2015-01-27
$EPI
ESSA Pharma Inc.
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: SPOUSE (Indirect Ownership)
Common Shares
54 - Exercise of warrants

+100 vol
31,350
Filed 2015-07-13
Tx date 2015-07-10
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Special Warrants
54 - Exercise of warrants

-363,636 vol
0
Filed 2015-07-13
Tx date 2015-07-10
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants

+363,636 vol
363,636
Filed 2015-07-13
Tx date 2015-03-05
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-06-05
Tx date 2015-03-15
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Special Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2015-06-05
Tx date 2015-03-05
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Special Warrants
00 - Opening Balance-Initial SEDI Report
363,636
Filed 2015-06-05
Tx date 2015-03-05
$EPI
ESSA Pharma Inc.
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
50,000